RE:RE:Resistance to ADCs in the treatment of solid tumors In the difficult context of all the highlighted issues with ADCs, Pfizer still acquired the ADC company Seagen for US$43 Billion last year, and will be seeking solutions to the issues discussed on this message board, through its continuing M&A activites.